Buy & Sell Cadence Design Systems Inc (CDNS) – Cadence Design Systems Inc Price Today
Aura AI Summary
Key Stats
- $103.04BMarket Cap
- TechnologySector
- -13.02%3M Drawdown
- $104.72BEnterprise Value
- -Dividend Yield
- 83% Buy | 17% SellTrading Activity
- 76 daysTypical Hold Time
Cadence Design Systems Inc (CDNS) is currently valued at a market capitalization of $103.04B, with an enterprise value of $104.72B. Over the past 52 weeks, Cadence Design Systems Inc has traded between a low of $265.66 and a high of $382.5, highlighting its annual price range. Over the past three months, Cadence Design Systems Inc has recorded a drawdown of -13.02%, reflecting recent price volatility. On average, investors hold Cadence Design Systems Inc for approximately 76 days, indicating typical investor behavior on the platform.
About Cadence Design Systems Inc
Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.
Most Recent News
ISS wins 7-year contract to provide 25,000 daily school meals in West Sussex, UK
ISS has secured a seven-year contract with West Sussex County Council to deliver around 25,000 nutritious school meals daily to primary schools starting Q3 2026. The contract, valued at about DKK 100 million annually, emphasizes inclusivity and high ...

argenx to present at major investor conferences in June, highlighting growth and new treatments.
argenx, a global immunology company focused on autoimmune diseases, announced its management team will present at two key investor conferences in June: the William Blair 46th Annual Growth Stock Conference and the Goldman Sachs 47th Annual Global Hea...

Capgemini targets 5.5-7.5% revenue CAGR by 2028, driven by AI transformation and margin expansion.
Capgemini announced its strategic direction focused on leveraging agentic AI to drive enterprise-wide transformation and business value. The company aims for a 5.5% to 7.5% compound annual revenue growth rate from 2025 to 2028, with margin expansion ...
